Treatment of chronic hepatitis B in Australia and New Zealand

[1]  T. Blakely,et al.  The incidence of hepatocellular carcinoma in New Zealand. , 1998, The New Zealand medical journal.

[2]  T. Blakely,et al.  Hepatitis B virus carrier prevalence in New Zealand: population estimates using the 1987 police and customs personnel survey. , 1998, The New Zealand medical journal.

[3]  B. Chapman,et al.  Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  A. Nicoll,et al.  REVIEW: Present and future directions in the treatment of chronic hepatitis B infection , 1997, Journal of gastroenterology and hepatology.

[5]  M. Burt,et al.  Evaluation of alpha interferon for the treatment of chronic hepatitis B infection in Christchurch. , 1996, The New Zealand medical journal.

[6]  N. Wilson,et al.  Acute hepatitis B resulting in hospitalisation in New Zealand. , 1996, The New Zealand medical journal.

[7]  Smith Bc,et al.  Management of the chronic hepatitis B carrier. , 1995 .

[8]  Stephen J. Williams,et al.  Interferon alfa for chronic active hepatitis B , 1995, The Medical journal of Australia.

[9]  G. Dusheiko,et al.  Comparative study of three doses of interferon‐α2a in chronic active hepatitis B , 1994 .

[10]  A. Milne,et al.  Kawerau revisited: hepatitis A and B seroprevalence in 1984 and 1993. , 1994, The New Zealand medical journal.

[11]  J. Waldon,et al.  Failure of New Zealand hepatitis B carriers to respond to Phyllanthus amarus. , 1994, The New Zealand medical journal.

[12]  L. Jennings,et al.  Concurrent hepatitis B and C infection treated successfully with alpha interferon. , 1993, Australian and New Zealand journal of medicine.

[13]  P. Angus,et al.  Combination antiviral therapy controls severe post‐liver transplant recurrence of hepatitis B virus infection , 1993, Journal of gastroenterology and hepatology.

[14]  G. Farrell.  Interferon treatment for chronic viral hepatitis in Australia: is it worth it? , 1992, The Medical journal of Australia.

[15]  I. Gust.  Control of hepatitis B in Australia: The case for alternative strategies , 1992, The Medical journal of Australia.

[16]  R. Stuart-Harris,et al.  The clinical application of the interferons: a review , 1992, The Medical journal of Australia.

[17]  S. Locarnini.  Design of new anti‐viral agents for chronic hepatitis B virus infection , 1991, Journal of gastroenterology and hepatology.

[18]  R. Batey,et al.  Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B. , 1990, Australian and New Zealand journal of medicine.

[19]  G. Farrell,et al.  Serial antipyrine clearance studies detect altered hepatic metabolic function during spontaneous and interferon‐induced changes in chronic hepatitis B disease activity , 1989, Hepatology.

[20]  G. Farrell.  Towards the eradication of hepatitis B in Australia. , 1988, Australian and New Zealand journal of medicine.

[21]  N. Pearce,et al.  Prevalence of hepatitis B infections in a multiracial New Zealand community. , 1985, The New Zealand medical journal.

[22]  T. Johnstone.  Notified viral hepatitis in New Zealand. , 1980, The New Zealand medical journal.